AssetMark Inc’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-281
| Closed | -$37.1K | – | 3150 |
|
|
2025
Q1 | $37.1K | Sell |
281
-2,003
| -88% | -$264K | ﹤0.01% | 1517 |
|
|
2024
Q4 | $191K | Sell |
2,284
-193
| -8% | -$16.1K | ﹤0.01% | 1107 |
|
|
2024
Q3 | $181K | Buy |
2,477
+207
| +9% | +$15.1K | ﹤0.01% | 1034 |
|
|
2024
Q2 | $155K | Buy |
2,270
+243
| +12% | +$16.6K | ﹤0.01% | 1038 |
|
|
2024
Q1 | $140K | Sell |
2,027
-209
| -9% | -$14.5K | ﹤0.01% | 1005 |
|
|
2023
Q4 | $160K | Buy |
2,236
+338
| +18% | +$24.2K | ﹤0.01% | 958 |
|
|
2023
Q3 | $98.9K | Buy |
1,898
+103
| +6% | +$5.37K | ﹤0.01% | 985 |
|
|
2023
Q2 | $114K | Buy |
1,795
+1,035
| +136% | +$65.5K | ﹤0.01% | 923 |
|
|
2023
Q1 | $41.2K | Buy |
760
+125
| +20% | +$6.77K | ﹤0.01% | 1077 |
|
|
2022
Q4 | $33.6K | Hold |
635
| – | – | ﹤0.01% | 1123 |
|
|
2022
Q3 | $30K | Buy |
635
+125
| +25% | +$5.91K | ﹤0.01% | 1055 |
|
|
2022
Q2 | $29K | Buy |
510
+410
| +410% | +$23.3K | ﹤0.01% | 1051 |
|
|
2022
Q1 | $6K | Buy |
100
+40
| +67% | +$2.4K | ﹤0.01% | 1259 |
|
|
2021
Q4 | $3K | Buy |
+60
| New | +$3K | ﹤0.01% | 1336 |
|